3SBio drops most in seven months on unit spin-off plans

3SBio

21/11/2025 06:15

** Shares of biopharmaceutical product producer 3SBio Inc 1530.HK drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28

** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold

** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit Mandi Inc on the main board of the Hong Kong stock exchange

** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing

** YTD, stock up 400%, Hang Seng Biotech Index .HSBIO up 77%

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))